Incivek Approval History
FDA Approved: Yes (Discontinued) (First approved May 23, 2011)
Brand name: Incivek
Generic name: telaprevir
Dosage form: Tablets
Company: Vertex Pharmaceuticals Incorporated
Treatment for: Hepatitis C
Marketing Status: Discontinued
Incivek (telaprevir) is a hepatitis C virus (HCV) NS3/4A protease inhibitor indicated, in combination with peginterferon alfa and ribavirin, for the treatment of chronic hepatitis C (CHC).
Development History and FDA Approval Process for Incivek
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.